thrombin receptor peptide sfllrnp has been researched along with ticlopidine in 12 studies
| Studies (thrombin receptor peptide sfllrnp) | Trials (thrombin receptor peptide sfllrnp) | Recent Studies (post-2010) (thrombin receptor peptide sfllrnp) | Studies (ticlopidine) | Trials (ticlopidine) | Recent Studies (post-2010) (ticlopidine) |
|---|---|---|---|---|---|
| 92 | 10 | 29 | 10,289 | 1,893 | 4,671 |
| Protein | Taxonomy | thrombin receptor peptide sfllrnp (IC50) | ticlopidine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.382 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 6.2928 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.304 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.175 | |
| Cytochrome P450 2B6 | Homo sapiens (human) | 0.405 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.6678 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.426 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassus, S; Franz, N; Graff, J; Harder, S; Kirchmaier, CM; Klinkhardt, U; Schini-Kerth, VB | 1 |
| Théroux, P; Xiao, Z | 1 |
| Baumann, PQ; Schneider, DJ; Sobel, BE; Whitaker, DA | 1 |
| Harder, S; Klinkhardt, U | 1 |
| Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Hernández, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Ramírez, C; Sabaté, M | 1 |
| Brandt, JT; Farid, NA; Jakubowski, JA; Lachno, DR; Li, YG; Naganuma, H; Payne, CD; Weerakkody, GJ; Winters, KJ | 1 |
| Diodati, JG; Lordkipanidzé, M; Nguyen, TA; Pharand, C; Schampaert, E | 1 |
| Bjørnsen, S; Brosstad, F; Erikssen, G; Meen, Ø; Pedersen, TM | 1 |
| Grgurevich, S; Jacoski, MV; Jennings, LK; Li, JS; Michelson, AD; Tyagi, A | 1 |
| Bobbert, P; Bobbert, T; Rauch, U; Schultheiss, HP; Schütte, C; Steffens, D; Stellbaum, C | 1 |
| Conyers, JL; Dong, JF; Fu, Y; Li, M; Liu, L; Liu, X; Yang, X; Zaske, AM; Zhang, J; Zhang, Y; Zhou, Z | 1 |
| Bode, C; Brandt, C; Diehl, P; Moser, M; Olivier, CB; Olschewski, M; Schnabel, K; Weik, P; Zhou, Q | 1 |
5 trial(s) available for thrombin receptor peptide sfllrnp and ticlopidine
| Article | Year |
|---|---|
Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; CD40 Ligand; Clopidogrel; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2004 |
Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aspirin; Bleeding Time; Clopidogrel; Collagen; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Peptide Fragments; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2007 |
Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition.
Topics: Adenosine Diphosphate; Adult; Alprostadil; Clopidogrel; Double-Blind Method; Female; Humans; Male; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prospective Studies; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Sample Size; Ticlopidine | 2008 |
Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: a comparative study of platelet aggregation response.
Topics: Adenosine Diphosphate; Adult; Arteries; Blood Platelets; Child, Preschool; Clopidogrel; Double-Blind Method; Female; Fetal Blood; Heart; Heart Diseases; Humans; Infant; Infant, Newborn; Male; Peptide Fragments; Placebos; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine | 2012 |
A high ratio of ADP-TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced aggregation alone.
Topics: Adenosine Diphosphate; Aged; Coronary Artery Disease; Female; Follow-Up Studies; Germany; Humans; Male; Myocardial Revascularization; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Receptors, Cell Surface; Stents; Survival Rate; Ticlopidine | 2014 |
7 other study(ies) available for thrombin receptor peptide sfllrnp and ticlopidine
| Article | Year |
|---|---|
Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Blood Platelets; Clopidogrel; Cytoplasmic Granules; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Male; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet-Derived Growth Factor; Ticlopidine | 2002 |
Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen.
Topics: Adenosine Diphosphate; Aged; Binding, Competitive; Blood Platelets; Clopidogrel; Coronary Artery Disease; Data Interpretation, Statistical; Eptifibatide; Fibrinogen; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Iodine Radioisotopes; Male; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
Topics: Adenosine Diphosphate; Adult; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clopidogrel; Flow Cytometry; Heart Diseases; Humans; Leukocytes; Male; Monocytes; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk; Ticlopidine | 2005 |
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Collagen Type I; Diabetes Mellitus; Drug Resistance; Drug Therapy, Combination; Epinephrine; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Vasoconstrictor Agents | 2006 |
Variability in aggregometry response before and after initiation of clopidogrel therapy.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Case-Control Studies; Clopidogrel; Demography; Female; Humans; Male; Middle Aged; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Reproducibility of Results; Ticlopidine | 2009 |
Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Postmenopause; Prospective Studies; Sex Factors; Ticlopidine | 2012 |
Contact- and agonist-regulated microvesiculation of human platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cell Shape; Cell-Derived Microparticles; Clopidogrel; Fibrinogen; Humans; Microscopy, Atomic Force; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2013 |